161 North Clark Street | Suite 4925 | Chicago, Illinois 60601-3296
  • RSS Feed
  • Facebook
  • Google +
  • Linked In
  • Twitter
Call Today 312-470-6761

About

The skilled Illinois accident attorneys at Phillips Law Offices are often asked by their opposing counsel-and even their opponents-to represent their family and friends in personal injury and wrongful death matters. This fact speaks volumes about the nature of our practice.

Phillips Law Offices is one of the oldest firms in Illinois concentrating in personal…

Learn More ›

Products Liability Blog Post

J&J Takes A Fall: Can the Public Put Their Trust in Major Pharmaceutical Companies?

For decades, Johnson & Johnson has been a corporate pillar in the pharmaceutical industry. After being hit with multiple product liability lawsuits, it appears that the company's rock-solid foundation is crumbling. Although Johnson & Johnson grosses more than $65 billion annually, public confidence is dwindling. Recently, the company set aside $600 million to pay a massive fine. Media outlets report that the funds will cover settlements on multiple lawsuits. These suits were related to improperly marketing several pharmaceuticals and for bribing officials overseas.

Legal actions ongoing

In court, J&J is battling lawsuits regarding the antipsychotic medication Risperdal®. The company was sued for failing to publish information about the drug's risks. In April 2012, the judge handling the case rendered a $1.1 billion verdict. A J&J spokeswoman said that the company would be appealing the ruling or seeking a new trial. On top of this massive award, J&J is facing lawsuits in other states. Judges for two of these cases ordered the company to pay nearly $600 million for similar allegations regarding Risperdal. J&J also paid $158 million to settle a Risperdal case in another state.

Johnson & Johnson is also facing lawsuits related to the medications Invega® and Natrecor®, which the company allegedly marketed for unapproved uses. Amid this never-ending stream of lawsuits, J&J has been charged with distributing kickbacks to artificially increase the sales of Risperdal to nursing home patients. If these allegations are true, Johnson & Johnson will be facing more penalties. The company's new CEO, who was hired in late April 2012, has said publicly that the company is attempting to restore its image and to boost the confidence of consumers and investors.

These judgments should warn patients in Illinois who are currently taking any of these medications. Patients should discuss the potential risks with their doctor. If you believe you have been injured by a Johnson & Johnson medication, call the experienced medical product liability attorneys at the Phillips Law Offices in Chicago.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

In order to help you more quickly, please fill out the quick form and submit.

  • This field is for validation purposes and should be left unchanged.
Contact Form
Phillips Law Offices
161 North Clark Street, Suite 4925
Chicago, Illinois, 60601-3296 USA
312-470-6761